PharmGen Science Inc (004720) — Cash Flow Reinvestment Rate
PharmGen Science Inc (004720) has a Cash Flow Reinvestment Rate of 0.78x as of September 2025, reinvesting ₩1.48 Billion (capex ₩799.96 Million plus investments ₩-680.92 Million) from operating cash flow of ₩1.91 Billion. Check 004720 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
PharmGen Science Inc Cash Flow Reinvestment Rate (2011–2024)
Historical reinvestment intensity for PharmGen Science Inc across 10 annual periods. Explore PharmGen Science Inc (004720) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for PharmGen Science Inc (2011–2024)
Year-by-year capital reinvestment analysis for PharmGen Science Inc. For live market cap and broader valuation context, see 004720 market cap.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.54x | ₩3.67 Billion | ₩2.38 Billion | ₩2.78 Billion | ▲ +74.9% |
| 2023 | 0.88x | ₩4.79 Billion | ₩5.44 Billion | ₩3.29 Billion | ▼ -78.7% |
| 2021 | 4.14x | ₩32.25 Billion | ₩7.78 Billion | ₩30.75 Billion | ▲ +126.7% |
| 2020 | 1.83x | ₩4.89 Billion | ₩2.68 Billion | ₩4.34 Billion | ▼ -55.8% |
| 2019 | 4.14x | ₩10.44 Billion | ₩2.52 Billion | ₩6.16 Billion | ▲ +84.6% |
| 2018 | 2.24x | ₩9.45 Billion | ₩4.22 Billion | ₩892.34 Million | ▲ +161.2% |
| 2017 | 0.86x | ₩1.58 Billion | ₩1.84 Billion | ₩1.54 Billion | ▼ -65.4% |
| 2016 | 2.48x | ₩19.26 Billion | ₩7.75 Billion | ₩3.43 Billion | ▲ +123.6% |
| 2015 | 1.11x | ₩4.02 Billion | ₩3.62 Billion | ₩771.87 Million | ▲ +400.3% |
| 2011 | 0.22x | ₩642.43 Million | ₩2.89 Billion | ₩642.43 Million | — |